Home › Decisions › IONS 2026-06-24

IONS FDA decision — Jun 24, 2026

✓ APPROVED

Ionis Pharmaceuticals Inc. — TRYNGOLZA (olezarsen) - (CORE) · Hypertriglyceridemia.

Run-up into the decision (T-120 → T+5)

Daily close, T-120 (1/7/26) through T+5. Run-up high $86.5 on 2/12/26, low $69.68 on 3/27/26 (T-120 to T-1). FDA decision 6/24/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-06-24

OutcomeApproved

Drug / candidateTRYNGOLZA (olezarsen) - (CORE)

CompanyIonis Pharmaceuticals Inc.

120-day run-up (T-120→T-1)-3.8%